Literature DB >> 21791938

Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia.

Do-Hyun Kim1, Han-Suk Kim, Chang Won Choi, Ee-Kyung Kim, Beyong Il Kim, Jung-Hwan Choi.   

Abstract

BACKGROUND: Despite the potential importance of pulmonary artery hypertension (PAH) in preterm infants with bronchopulmonary dysplasia (BPD), little is known about the risk factors for PAH.
OBJECTIVES: To investigate the risk factors for PAH in preterm infants with BPD.
METHODS: Infants diagnosed with BPD were assigned to the PAH group or non-PAH group except for infants with mild BPD who had no PAH. PAH was diagnosed on the basis of echocardiograms demonstrating elevated right ventricle pressure beyond the postnatal age of 2 months. Logistic regression analysis was done for the multivariate assessment of the risk factors for PAH in preterm infants with moderate or severe BPD.
RESULTS: A total of 98 infants among 145 infants with BPD were divided into a PAH group (n = 25) or non-PAH group (n = 73), while the remaining 47 infants had mild BPD with no PAH. Among the study patients, survival rate of the PAH group was significantly lower than that of the non-PAH group. Infants with PAH had more severe cases of BPD and underwent longer durations of oxygen therapy, conventional or high-frequency ventilation, and hospitalization compared to those without PAH. Low 5-min Apgar scores (≤6; relative risk (RR) 6.2; 95% confidence interval (CI) 1.4-28.0; p = 0.017) and oligohydramnios (RR 7.7; 95% CI 2.0-29.6; p = 0.030) were found to be significant risk factors for PAH according to multivariate analysis.
CONCLUSIONS: The present study shows that oligohydramnios is a specific risk factor for PAH in preterm infants with moderate or severe BPD.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21791938     DOI: 10.1159/000327891

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  54 in total

Review 1.  Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Lewis H Romer; Bridget D Stuart; John D Coulson; Allen D Everett; Edward E Lawson; Joel I Brenner; Anna T Brown; Melanie K Nies; Priya Sekar; Lawrence M Nogee; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2012-07-06

2.  Mortality among infants with evolving bronchopulmonary dysplasia increases with major surgery and with pulmonary hypertension.

Authors:  L B DeVries; R J Heyne; C Ramaciotti; L S Brown; M A Jaleel; V S Kapadia; P J Burchfield; L P Brion
Journal:  J Perinatol       Date:  2017-06-15       Impact factor: 2.521

3.  Bronchopulmonary Dysplasia and Pulmonary Hypertension. The Role of Smooth Muscle adh5.

Authors:  Thomas M Raffay; Koby Bonilla-Fernandez; Anjum Jafri; Ramadan B Sopi; Laura A Smith; Feifei Cui; Maureen O'Reilly; Rongli Zhang; Craig A Hodges; Peter M MacFarlane; Gail Deutsch; Richard J Martin; Benjamin Gaston
Journal:  Am J Respir Cell Mol Biol       Date:  2021-07       Impact factor: 6.914

4.  Pulmonary hypertension in premature infants. Sharpening the tools of detection.

Authors:  Kathryn N Farrow; Robin H Steinhorn
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

Review 5.  Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.

Authors:  G Al-Ghanem; P Shah; S Thomas; L Banfield; S El Helou; C Fusch; A Mukerji
Journal:  J Perinatol       Date:  2017-01-12       Impact factor: 2.521

6.  Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension.

Authors:  Jennifer K Trittmann; Eric Peterson; Lynette K Rogers; Bernadette Chen; Carl H Backes; Mark A Klebanoff; Leif D Nelin
Journal:  J Pediatr       Date:  2014-10-11       Impact factor: 4.406

7.  Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Infants with Bronchopulmonary Dysplasia.

Authors:  M N Trottier-Boucher; A Lapointe; J Malo; A Fournier; M J Raboisson; B Martin; A Moussa
Journal:  Pediatr Cardiol       Date:  2015-04-01       Impact factor: 1.655

Review 8.  The Robyn Barst Memorial Lecture: Differences between the fetal, newborn, and adult pulmonary circulations: relevance for age-specific therapies (2013 Grover Conference series).

Authors:  Steven H Abman; Christopher Baker; Jason Gien; Peter Mourani; Csaba Galambos
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

Review 9.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Sara K Berkelhamer; Karen K Mestan; Robin H Steinhorn
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 10.  Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia.

Authors:  Peter M Mourani; Steven H Abman
Journal:  Clin Perinatol       Date:  2015-09-26       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.